key: cord-0901115-26cb1hyr
authors: Evans, Colin E.; Iruela-Arispe, M. Luisa; Zhao, You-Yang
title: Mechanisms of Endothelial Regeneration and Vascular Repair and Their Application to Regenerative Medicine
date: 2020-10-15
journal: Am J Pathol
DOI: 10.1016/j.ajpath.2020.10.001
sha: f006cdbd22082e6dcb08fd4ab8d0e29dc47ba430
doc_id: 901115
cord_uid: 26cb1hyr

Endothelial barrier integrity is required for maintaining vascular homeostasis and fluid balance between the circulation and surrounding tissues and for preventing the development of vascular disease. Despite comprehensive understanding of the molecular mechanisms and signaling pathways mediating endothelial injury, the regulatory mechanisms responsible for endothelial regeneration and vascular repair are incompletely understood and constitutes an emerging area of research. Endogenous and exogenous reparative mechanisms serve to reverse vascular damage and restore endothelial barrier function through regeneration of a functional endothelium and re-engagement of endothelial junctions. In this review, mechanisms that contribute to endothelial regeneration and vascular repair are described. These mechanisms could be targeted to improve outcome in diseases that are characterized by vascular injury such as atherosclerosis, restenosis, peripheral vascular disease, sepsis, and acute respiratory distress syndrome. Future studies to further improve current understanding of the mechanisms that control endothelial regeneration and vascular repair are also highlighted.

Endothelial cells (ECs) line the inner wall of blood vessels and form a semi-permeable barrier, which regulates the flux of fluid, proteins and blood cells across the vascular wall into parenchymal tissue and maintains an anti-thrombotic and anti-inflammatory state of the microvascular bed 1, 2 . Endothelial injury leads to complications associated with inflammation including increased vascular permeability, transmigration of inflammatory cells, exit of erythrocytes, tissue edema, and microthrombosis 3 . Endothelial barrier dysfunction is a key initiating event of various vascular diseases including atherosclerosis and in-stent restenosis 1 .

Evidence from humans and animals has demonstrated the central role of endothelial leakage in determining the outcome of vascular diseases including sepsis-induced lung injury [4] [5] [6] [7] [8] [9] [10] . A better mechanistic understanding of endothelial regeneration and vascular repair is therefore of pivotal importance in the development of novel therapeutic strategies to promote endothelial integrity and vascular health.

Following endothelial injury, the vascular repair process involves restoration of a functional endothelial monolayer (i.e., endothelial regeneration) and re-establishment of the endothelial junctions to re-form a semi-permeable barrier (Figure 1 ). Endothelial regeneration may involve resident ECs themselves (i.e. endogenous), and/or cells other than the resident EC population such as the circulating stem/progenitor cells (i.e. exogenous). Mechanisms that regulate endothelial barrier development and injurious junction leakage have been reviewed thoroughly by others 11 . The current review describes the cellular and molecular mechanisms that control endothelial regeneration and recovery of endothelial barrier function following injury.

Major unanswered research questions pertaining to endothelial regeneration and vascular repair are identified herein, and future studies that could improve understanding of regenerative and reparative endothelial signaling are also discussed.

endothelial regeneration. The process of endothelial regeneration has been considered to involve resident EC migration and proliferation and/or recruitment of circulating stem/endothelial progenitor cells (EPCs) that differentiate to ECs. Since the identification of circulating EPCs derived from the bone marrow (BM) 12 , investigating the role of EPCs in endothelial regeneration and vascular repair has become an active area of research [13] [14] [15] . Studies have shown that some circulating cells express the same surface markers and exhibit some properties in vitro similar to mature ECs 16, 17 . These studies indicate that circulating stem/progenitor cells may engraft into and function to regenerate the damaged endothelium. However, amounting evidence shows that circulating EPCs (most likely monocytic) do not directly contribute to endothelial regeneration by forming part of the regenerating endothelium. Employing BM cell transplantation and an EC-specific reporter, Ohle et al. 18 have revealed a rare population of BM-derived cells (CD45 -/CD31 + /CD144 + ) in recipient human lungs at 1 year after transplantation, but these cells were not found in the anatomic compartment of the pulmonary vascular endothelium, indicating no involvement in endothelium maintenance. Furthermore, the study found no contribution of BM-derived cells to the endothelium of the adult lung, heart, liver, pancreas or kidney after hyperoxic injury and recovery. In a study of lipopolysaccharide (LPS)induced lung injury in mice, Kawasaki et al. found that pulmonary EC number markedly decreases at one day post-LPS administration while returns to baseline by day 7. Subsequent studies with GFP + BM chimera mice revealed only a limited amount (∼2%) of engraftment of BM-derived ECs. However, GFP + ECs don't proliferate with minimal changes of total GFP + ECs which in fact decrease ∼0.5% from 2% during the recovery from LPS-induced injury 19 . Studies with direct GFP + BM cell transplantation without irradiation also show that BM GFP+ cells hardly engrafted to pulmonary vascular endothelium or proliferated during the regenerative process.

The total number of circulating EPCs (either Flk1/KDR + /CD133 + or Flk1/KDR + /CD34 + ) is below the basal levels by day 7 following lung injury indicating no engraftment to the injured lung endothelium 19 . Hagensen et al. also attempted to determine the role of circulating cells in endothelial regeneration 20 . Wire-injured carotid artery segments from wildtype mice were transplanted into Tie2-GFP mice demonstrating that the neo-endothelium was negative for GFP, suggesting that circulating cells including BM-derived EPCs don't directly engraft to the injured endothelium to form a part of the regenerated endothelium. Employing pairs of genetically marked parabiotic mice with a shared anastomosed circulatory system, Purhonen et al. also demonstrated that BM-derived circulating endothelial precursors do not contribute to endothelial regeneration 21 .

Intriguingly, Singhal et al. provided evidence of the contribution of BM-derived circulating cells to vascular repair in a murine hepatectomy model, but these cells did not directly contribute to endothelial regeneration by forming the regenerating endothelial layer 22 . Employing a partial hepatectomy model as well as chronic liver damage models where the liver vascular endothelium remains intact, Singhal et al. observed no BM-derived cell incorporation into the new vessels. Following irradiation-induced EC damage, BM-derived mononuclear cells were recruited and incorporated into the vasculature, but these cells failed to differentiate to ECs.

Together, the recent studies using genetic lineage tracing and experimental parabiosis as well as advanced imaging techniques provide convincing evidence that BM-derived cells and circulating EPCs are not the major source of ECs that make up the regenerating endothelium.

Nevertheless, endothelial regeneration and vascular repair seems to benefit from factors released from circulating progenitor cells, and such factors could play a role in these regenerative and reparative process (Figure 1); these exogeneous paracrine mechanisms are described later in the article.

To gain insights into the role of tissue resident ECs in the mechanism of endothelial regeneration, studies employ J o u r n a l P r e -p r o o f genetic lineage tracing and other approaches. Employing Tie2Cre-GFP mice, Itoh et al. found that recovery of the EC-denuded middle cerebral artery by photochemical injury required a combination of resident EC elongation and migration from both ends of the injury site and resident EC proliferation, without observing involvement of exogenous progenitor cells 23 . Their findings were further supported on mouse model of aortic EC injury induced by compression clamping and a genetic lineage tracing (Cdh5Cre-ERT2) approach 24 . In those studies, McDonald et al. showed that regenerating ECs arose from sites immediately adjacent to the site of injury with no contribution from circulating cells. These authors also demonstrated that the regenerative ECs (80% of them are Cdh5 + /Atf3 + ) altered their transcriptional profile and acquire significant proliferative potential. The process relies on activation of key stress response genes, particularly activating transcription factor 3 (ATF3). They also showed that the regenerative response is significantly impaired in older mice where levels of Atf3 decline. Regarding the contribution of resident ECs to endothelial regeneration in the murine liver, Singhal et al.

showed that regeneration was mediated solely by resident ECs (Cdh5Cre-ERT2-mediated labeling) when resident ECs were intact following partial hepatectomy or carbon tetrachlorideinduced chronic damage or adenoviral infection. When resident ECs were damaged via irradiation, BM-derived cells were recruited and incorporated into the injured vasculature, but these cells failed to differentiate to ECs 22 . A recent study using genetic lineage tracing with Cre recombinase expression driven by the 5' endothelial enhancer of the stem cell leukemia locus (EndoSCL-CreERT2) demonstrated that the resident EC population drops in number following inflammatory lung injury in mice, then recovers to a level similar to that found at baseline; this study also identified an increase in lung EC proliferation during recovery from sepsis challenge 25 . Thus, lung endothelial regeneration is mediated by tissue resident EC proliferation following inflammatory vascular injury 9 . These studies together provide strong evidence that the tissue resident EC population is the major cell source of regenerating ECs during endothelial J o u r n a l P r e -p r o o f regeneration (Figure 1 ), but the specific main driving mechanisms might be distinct in large versus small vessels and distinct in different organs, which will be discussed below.

Heterogeneity is a characteristic feature of ECs 26, 27 . Recent studies have tried to identify and define potential specialized tissue-resident ECs responsible for endothelial regeneration. In a study mentioned above, Kawasaki et al. demonstrated that a subpopulation of lung resident ECs (CD34 + /Flk-1/KDR + /c-kit + ) with progenitor cell characteristics is largely responsible for lung endothelial regeneration following acute lung injury in mice 19 . Experiments using BM chimeric mice revealed that most of the regenerating pulmonary vascular ECs are tissue-resident cells, whereas BM-derived cells barely engrafted as pulmonary vascular ECs. The regenerating pulmonary vascular ECs were characterized by high colony-forming and vasculogenic capacities with high expression of CD34, Flk-1/KDR, and c-kit and low expression of Prom1/CD133 on the cell surface when compared with non-proliferating pulmonary vascular ECs. In a study by Wakabayashi et al., a sub-population of CD157-expressing regenerative tissue-resident endothelial stem cells was identified in the arteries and veins but not capillaries of numerous mouse organs, including liver, lung, heart, skeletal muscle, skin, retina, and brain 28 . These cells were able to regenerate entire vasculature structures following injury and maintain large vessels in the healthy liver for >12months. As discussed above, McDonald et al. tracing. Additionally, there is an interesting subpopulation called mesoangioblasts. These vessel-associated multipotent cells often express endothelial and/or pericyte markers such as platelet-derived growth factor receptor β (PDGFRβ), CD271, CD73, EMCN, and DLK1 29, 30 , and are able to form vessel-like structures 31 . While the contribution of mesoangioblasts to cardiac regeneration has been well studied 30, 32 , the role of mesoangioblasts in endothelial regeneration and vascular repair remains unclear.

FoxM1. FoxM1 is a member of the mammalian Forkhead Box family of transcription factors that share homology in the winged helix or Forkhead DNA binding domain 33 . FoxM1 expression is markedly induced in lung ECs in the recovery phase but not in the injury phase after endotoxemia 9 . The role of this transcription factor in the recovery of the pulmonary endothelium following injury has been investigated using mice lacking endothelial FoxM1 9 . ECspecific Foxm1 knockout mice exhibited impaired EC proliferation and persistent increases in lung vascular permeability despite a similar degree of peak injury compared with wild type mice.

Overexpression of FoxM1 enhanced endothelial proliferation and thus facilitated the recovery of endothelial barrier integrity and promoted survival 34 .

HIF-1α α α α. Hypoxia-inducible factors (HIFs) are critical mediators of the adaptive response to hypoxia and ischemia. These heterodimeric proteins consist of a constitutively expressed β subunit and an oxygen-labile α subunit that has 3 isoforms (HIF-1α, HIF-2α, and HIF-3α) 35 Atf3. In the regenerating endothelium of large murine blood vessels, the stressinducible transcription factor, ATF3, is a key transcription factor 24 . ATF3 is a member of the ATF/CREB family of transcription factors involved in many human diseases including cancer and atherosclerosis 39, 40 . ATF3 is highly expressed in proliferating ECs following mechanical pressure injury of the murine aortic endothelium imposed by a clamp 24 . Global Atf3 knockout mice show a significant reduction in EC proliferative capacity and defective endothelial regeneration resulting in impaired wound closure following mechanical pressure-induced injury of the aortic endothelium.

P110γ γ γ γPI3K signaling. Huang 

While evidence reviewed earlier in the article suggests that non-resident/circulating cells are not a major source of regenerating endothelium, circulating EPC numbers are correlated with disease risk, severity, or outcome in conditions that are characterized by vascular injury J o u r n a l P r e -p r o o f such as cerebrovascular disease and sepsis 63, 64 . Exogenous administration of mesenchymal stem cells (MSCs) or BM-derived progenitor cells can inhibit inflammatory lung injury and promote survival following sepsis challenge [65] [66] [67] [68] [69] [70] [71] [72] . Importantly, MSC therapy shows promise for treatment of ARDS patients 73, 74 . It is now thought that BM-derived cells as well as exogenously administered adult stem cells (e.g., MSCs) could promote endothelial regeneration and vascular repair through paracrine mechanisms, particularly given the studies described above showing that these cell types rarely engraft into the vasculature.

One such study clearly demonstrated the paracrine function of these stem/progenitor cells in promoting endothelial regeneration and vascular repair 75 Other studies have revealed that smooth muscle cells can also drive EC regeneration. 

Improved understanding of the cellular and molecular mechanisms that control the intrinsic endothelial regenerative and reparative processes could lead to the development of novel and effective treatments for diseases characterized by EC injury and dysfunction. As described in this review, multiple transcription factors and signaling pathways that control the intrinsic endothelial regeneration and vascular repair process have been identified (Figures 2,   3 , and Table 1 ). Although intuitive, it has been convincingly demonstrated that endothelial regeneration is significantly impaired with aging, at least in large vessels 24 Endothelial FoxM1 is one of the endogenous mediators of the paracrine effects. Vascular repair also involves re-annealing of endothelial cell-cell junctions to re-form a semi-permeable barrier.

One study shows that β-catenin is the transcriptional target of FoxM1. Endothelial 

Endothelial function and dysfunction: testing and clinical relevance

Endothelial cells in physiology and in the pathophysiology of vascular disorders

Inflammation and atherosclerosis

The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome

Microvascular blood flow is altered in patients with sepsis

Broken barriers: a new take on sepsis pathogenesis

FoxM1 regulates reannealing of endothelial adherens junctions through transcriptional control of beta-catenin expression

Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock

Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury

Endothelial p110gammaPI3K Mediates Endothelial Regeneration and Vascular Repair After Inflammatory Vascular Injury

Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability

Isolation of putative progenitor endothelial cells for angiogenesis

Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair

Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells

Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease

Stem cells and the vasculature

Endothelial Progenitors: A Consensus Statement on Nomenclature

Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells

Vascular Repair by Tissue-Resident Endothelial Progenitor Cells in Endotoxin-Induced Lung Injury

Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury

Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth

Endothelial cell fitness dictates the source of regenerating liver vasculature

Resident endothelial cells surrounding damaged arterial endothelium reendothelialize the lesion

Endothelial Regeneration of Large Vessels Is a Biphasic Process Driven by Local Cells with Distinct Proliferative Capacities

Sox17 is required for endothelial regeneration following inflammation-induced vascular injury

Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration

CD157 Marks Tissue-Resident Endothelial Stem Cells with Homeostatic and Regenerative Properties

The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells

Hepatocyte growth factor mobilizes non-bone marrow-derived circulating mesoangioblasts

Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts

Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: a comparison with bone marrow progenitors, fibroblasts, and endothelial cells

Unified nomenclature for the winged helix/forkhead transcription factors

Transgenic expression of FoxM1 promotes endothelial repair following lung injury induced by polymicrobial sepsis in mice

Update on hypoxia-inducible factors and hydroxylases in oxygen regulatory pathways: from physiology to therapeutics

HIF-1 and HIF-2: working alone or together in hypoxia?

Endothelial Hypoxia-Inducible Factor-1alpha Is Required for Vascular Repair and Resolution of Inflammatory Lung Injury through Forkhead Box Protein M1

Role of SOX17 in hematopoietic development from human embryonic stem cells

Aderem A: ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation

Opposing roles for calcineurin and ATF3 in squamous skin cancer

MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1

Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes

Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury

Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis

VEGF(165) mediates glomerular endothelial repair

Vascular permeability factor accelerates endothelial regrowth following balloon angioplasty

Transfection of the DNA for the receptor KDR/flk-1 attenuates neointimal proliferation and luminal narrowing in a coronary stent angioplasty model

Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury

Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice

Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury

VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity

N-cadherin signaling via Trio assembles adherens junctions to restrict endothelial permeability

The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of beta-catenin phosphorylation

The G protein betagamma subunit mediates reannealing of adherens junctions to reverse endothelial permeability increase by thrombin

Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair

Metformin-stimulated AMPK-alpha1 promotes microvascular repair in acute lung injury

N-cadherin coordinates AMP kinase-mediated lung vascular repair

Preservation of microvascular barrier function requires CD31 receptor-induced metabolic reprogramming

Natarajan V: Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation

MicroRNA-150 Suppression of Angiopoetin-2 Generation and Signaling Is Crucial for Resolving Vascular Injury

Endothelial progenitor cells during cerebrovascular disease

Endothelial progenitor cells in regeneration after acute lung injury: do they play a role?

Requirement of alpha(4)beta(1) and alpha(5)beta(1) integrin expression in bone-marrow-derived progenitor cells in preventing endotoxininduced lung vascular injury and edema in mice

Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability

Intrapulmonary delivery of bone marrowderived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice

Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung

Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria

Bone marrow progenitor cells induce endothelial adherens junction integrity by sphingosine-1-phosphate-mediated Rac1 and Cdc42 signaling

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial

Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS

Endothelial FoxM1 mediates bone marrow progenitor cell-induced vascular repair and resolution of inflammation following inflammatory lung injury

In vitro secreting profile of human mesenchymal stem cells

Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action

Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease

The many faces of endothelial microparticles

Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA

Microparticles in endothelial cell and vascular homeostasis: are they really noxious? Haematologica

CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization

Novel Paracrine Functions of Smooth Muscle Cells in Supporting Endothelial Regeneration Following Arterial Injury

Endothelial Regenerative Capacity and Aging: Influence of Diet, Exercise and Obesity

Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury

Chronic heart failure and aging -effects of exercise training on endothelial function and mechanisms of endothelial regeneration: Results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study

Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway

Metabolic control of the cell cycle

Central Role of Metabolism in Endothelial Cell Function and Vascular Disease

Arteries are formed by vein-derived endothelial tip cells

Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells

Functional Definition of Progenitors Versus Mature Endothelial Cells Reveals Key SoxF-Dependent Differentiation Process

Generation of functional blood vessels from a single c-kit+ adult vascular endothelial stem cell

Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell-Derived Chemokine (C-C Motif) Ligand 2 and Chemokine (C-X-C motif) Ligand 1 Contributes to Neointima Formation

Direct conversion of adult skin fibroblasts to endothelial cells by defined factors

ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells

Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels

The effects of stenting on shear stress: relevance to endothelial injury and repair

Decreased blood flow rate disrupts endothelial repair in vivo

Molecules that have either a beneficial (+) or inhibitory (-) impact on endothelial regeneration (ER) or junction re-annealing (JR) have been identified by experimental studies of isolated ECs and multiple organs and species. Abbreviations: CLP, cecal ligation and puncture